Lataa...
Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series
Methicillin-susceptible Staphylococcus aureus (MSSA) causes 45% of S. aureus bloodstream infections (BSI) and is the most important cause of BSI-associated death. The standard of care therapy is an anti-staphylococcal penicillin or cefazolin, but dosing frequencies for these agents are often infeasi...
Tallennettuna:
| Julkaisussa: | J Pharmacol Pharmacother |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5642131/ https://ncbi.nlm.nih.gov/pubmed/29081626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jpp.JPP_5_17 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|